Skip to search formSkip to main contentSkip to account menu

Blastic Plasmacytoid Dendritic Cell Neoplasm

Known as: Agranular CD4+ CD56+ Hematodermic Neoplasm/Tumor, Early Plasmacytoid Dendritic Cell Leukemia/Lymphoma, Blastic Natural Killer Leukemia/Lymphoma 
An aggressive immature hematologic neoplasm formerly known as blastic NK cell lymphoma, composed of cells with a lymphoblast-like morphology. Recent… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
@OncologyTimes Next Generation of CAR-T Cells Possible A new approach to programing cancer-fighting immune cells called CAR-T… 
2019
2019
ELZONRIS (tagraxofusp-erzs, Stemline® Therapeutics) Indications: Treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN… 
Review
2018
Review
2018
Purpose of ReviewEngagement on social media for professional, healthcare-related communication is rapidly rising around the world… 
Review
2017
Review
2017
Purpose of ReviewThe use of Twitter, one of the most commonly engaged social media platforms in the world, is increasing among… 
Review
2016
Review
2016
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematological malignancy that is derived… 
Review
2014
Review
2014
Introduction Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, highly aggressive hematopoietic malignancy. It… 
2012
2012
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), also known as CD4+/CD56+ hematodermic neoplasm, is a rare, highly… 
2011
2011
We describe a 75-year-old Japanese woman with blastic plasmacytoid dendritic cell neoplasm. On her first visit, there were… 
2011
2011
http://bloodjournal.hematologylibrary.org/content/118/17/4591.full.html Updated information and services can be found at: (971… 
2010
2010
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is the new name given by the World Health Organization (WHO) to the disease…